Medical Breakthroughs
Leadership
Health Evolution CEO Reading List
Chief executives of providers, payers and life sciences organizations can look to this frequently updated list for articles and resources about health care and leadership.
Read More
COVID
Data Dive: After a year of missed appointments, an increase in diagnoses is coming
Between March and August of last year, utilization of the health care system fell 23 percent, according to a research report. Here’s what that means for an increase in diagnoses across critical diseases.
Read More
COVID
Data dive: What deaths, infections and new vaccines suggest about herd immunity
With death rates and new infections currently on the decline and vaccine doses poised to surge is U.S. herd immunity just weeks away?
Read More
COVID
Pfizer’s COVID-19 vaccine: How will it be distributed and who will receive it first?
Now that its vaccine has demonstrated 90 percent efficacy in Phase 3 clinical trials, Pfizer SVP Peter Honig, MD discusses next steps, timelines for wide availability, and the work still ahead.
Read More
COVID
Four primary care disruptors discuss retail, COVID-19 and more
Health Evolution spoke with leaders at four different disruptor organizations to examine the changing primary care landscape. Use of tech, leveraging community partnerships, and advancing new models of care are a few of the ways these companies are driving growth.
Read More
Consumerism
Innovator CEO profile: Higi’s Jeff Bennett
Powered by Higi
In the Health Evolution Innovation Lab interview series, the veteran investor and startup executive explains how the company is looking to disrupt the need for in-person diagnostics to strengthen the doctor-patient relationship, what personalized medicine means to him, and the omnichannel future of patient engagement.
Next-Generation IT
CEOs discuss reshaping the global health care supply chain
GE Healthcare’s Kieran Murphy, Thermo Fisher’s Marc Casper, Cardinal Health’s current chief executive Mike Kaufmann and former Chairman and CEO George Barrett share insights about mobilizing quickly, forming partnerships, protecting the workforce and assessing readiness for distributing a vaccine.
Read More
COVID
The case for a COVID-19 human challenge: An interview with VBI Vaccines CEO Jeff Baxter
Administering a trial vaccine on 400-500 people and then exposing them to COVID-19 would present obstacles and ethical questions, Baxter said, but it could accelerate the process enough that he would be willing to participate as a patient.
Read More
Policy
Breaking down Trump’s executive orders on drug pricing
Experts discuss their skepticism about three of the rules and why a forthcoming additional one could ultimately be effective.
Read More
COVID
How COVID-19 has health care ‘reinventing’ innovation for therapeutics
Private-public partnerships have emerged, R&D is on the rise, progress is being made, now the industry needs real-world evidence.
Read MoreCOVID-19 Innovation Guide
The first report in a three-part series on COVID-19 innovation lessons learned by Providence, the pandemic's original ground zero in the U.S. Read the report.
